Lataa...

Rituximab and biosimilars – equivalence and reciprocity

Cancer is a debilitating disease affecting millions of people daily. Over the years, cancer treatment has advanced in leaps and bounds. Antibodies are important breakthrough therapeutic agents for cancer. These agents, proteins produced by B lymphocytes of the immune system in response to antigens,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Qureshi, Zaina P, Magwood, Jametta S, Singh, Sarveshwari, Bennett, Charles L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017581/
https://ncbi.nlm.nih.gov/pubmed/24829884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BS.S20681
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!